Physiologically Based Biopharmaceutics Modeling (PBBM)
Authors:
- 11 June 2021
- book chapter
- Published by Springer Nature
- p. 1-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In Vitro Biopredictive Methods: A Workshop Summary ReportJournal of Pharmaceutical Sciences, 2021
- Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2020
- Suitability of the z-Factor for Dissolution Simulation of Solid Oral Dosage Forms: Potential Pitfalls and RefinementsJournal of Pharmaceutical Sciences, 2020
- A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVPPharmaceutics, 2020
- Applications of Clinically Relevant Dissolution Testing: Workshop Summary ReportThe AAPS Journal, 2018
- Integration of&IT in vitro&IT biorelevant dissolution and &ITin&IT &ITsilico&IT PBPK model of carvedilol to predict bioequivalence of oral drug productsEuropean Journal of Pharmaceutical Sciences, 2018
- Comparison of Methods for Predicting Dissolution and the Theoretical Implications of Particle-Size-Dependent SolubilityJournal of Pharmaceutical Sciences, 2012
- On the use of the Weibull function for the discernment of drug release mechanismsInternational Journal of Pharmaceutics, 2006
- General solution for diffusion‐controlled dissolution of spherical particles. 1. TheoryJournal of Pharmaceutical Sciences, 1999
- THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.Journal of the American Chemical Society, 1897